These PI3K/MAPK pathway mutations include NRAS, KRAS, PIK3CA, PTEN, NF1, TSC1 and FGFR3. In two of the three pairs of primary NPC and local recurrence samples, RAS activating mutations were shown to be progression drivers. The gene discussed is PIK3CA; the disease is nasopharyngeal carcinoma.